CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Results of the first study on intraperitoneal virotherapy employing a recombinant vaccinia virus genetically engineered to selectively replicate in and destroy cancer cells
DOI 10.1055/s-0034-1385989
Bibliografische Angaben
Nachweis in CareLit
Autor:innenUM Lauer, J Beil, S Berchtold, M Zimmermann, U Koppenhöfer, M Bitzer, NP Malek, J Glatzle, A Königsrainer, R Möhle, F Fend, C Pfannenberg, T Auth, T Yu, AA Szalay
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: GL-ONC1 constitutes a recombinant Vaccinia virus genetically engineered to selectively replicate in and destroy cancer cells. Since GL-ONC1 encodes state-of-the-art marker genes, features of its tumor cell colonization, in-patient replication, and oncolysis can be tracked excellently. We here report our data obtained in patients with peritoneal carcinomatosis (PC) who have been recruited to our ongoing…
Zitieren
Zitierempfehlung
UM Lauer, J Beil, S Berchtold, M Zimmermann, U Koppenhöfer, M Bitzer, NP Malek, J Glatzle, A Königsrainer, R Möhle, F Fend, C Pfannenberg, T Auth, T Yu, AA Szalay (2014) Results of the first study on intraperitoneal virotherapy employing a recombinant vaccinia virus genetically engineered to selectively replicate in and destroy cancer cells. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0034-1385989
Mit CareLit weiterarbeiten